PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.\', \'Charbonneau Cancer Research Institute, Calgary, AB, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ejh.13552
?:hasPublicationType
?:journal
  • European journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 33197297
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.06
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all